IPAB: Nature of Jurisdiction, Power and Authority
2nd January, 2014 - 5:17 am
Categories:
IP Litigation
IP Practice in India
IPAB Decisions
Patent Litigation
Patents
0 Comments
Akash Patel, an intern at Khurana and Khurana, Advocates and IP Attorneys, looks at the nature of jurisdiction at the IPAB, its power and authority. In a judgment dated July 08, 2013, a larger bench of Intellectual Property Appellate Board (hereinafter read as IPAB) had decided on two important issues, one relating to IPAB’s power … Continue reading IPAB: Nature of Jurisdiction, Power and Authority
Read more »Microsoft’s Acquisition of Nokia
This is one of the most interesting and important news in technology sector. In case you missed it, the story is: Microsoft and Nokia announced on September 3 that Microsoft would be buying Nokia’s handset business and licensing various patents for about $7 billion. Many industry experts have already started debating about Microsoft’s acquisition of Nokia’s handset … Continue reading Microsoft’s Acquisition of Nokia
Read more »Monsanto’s Patent on Method of Producing Transgenic Plants refused by IPAB
Monsanto’s Indian patent application 2407/DEL/NP/2006 on transgenic plants with heat/salt/draught tolerant plants is rejected by IPAB. The subject patent application is directed to a method of producing a draught/stress/heat/salt/drug tolerant transgenic plants by inserting a recombinant DNA molecule that expresses a cold shock protein CspA or CspB. The subject patent application was rejected by the … Continue reading Monsanto’s Patent on Method of Producing Transgenic Plants refused by IPAB
Read more »Generic v. Branded patent battles in India foray into life management diseases too
18th April, 2013 - 6:03 am
Categories:
IP Practice in India
Pharma/Biotech Patent Litigations
0 Comments
Patent wars in India between the foreign innovator companies and the Indian generics now seem to be spreading over life-management diseases segment. Till now the patent infringement cases have revolved and are still revolving over drugs for life-threatening diseases such as HIV, cancer where the public interest has played an important factor in the adjudication … Continue reading Generic v. Branded patent battles in India foray into life management diseases too
Read more »Khurana and Khurana win an award from Corporate Intl Magazine
We are pleased to announce that our firm Khurana and Khurana Advocates and IP Attorneys has been chosen as the winner of 2013 Corporate Intl Magazine Legal Award for the category of ‘IP Patents Law Firm of the Year in India’. Since 2005, Corporate Intl has been firmly established as one of the leading monthly … Continue reading Khurana and Khurana win an award from Corporate Intl Magazine
Read more »Depository Material
Indian Patents Act provides an applicant to deposit a biological material in support of the Indian patent application. It is an exigent via which an applicant can cure what might otherwise be a conceivably fatal defect in a patent application or even for an issued patent. A “biological deposit” can, in that case, fulfil the … Continue reading Depository Material
Read more »Analysis of the Intellectual Property Rights (Imported Goods) Enforcement Rules, 2007
The Customs Act, 1962 prohibits import of those goods that infringed intellectual property. Under Section 11, the Central Government can prohibit import or export of goods that infringed patents, trademarks or copyrights, by issuing a notification. It also covered prevention of contravention of any law for the time being in force. Further, Section 111 and … Continue reading Analysis of the Intellectual Property Rights (Imported Goods) Enforcement Rules, 2007
Read more »IIPRD Offers 6 months Online Certificate Course
IIPRD (Institute of Intellectual Property Research and Development) offers a Six Months Certificate Course on “Patent Portfolio Creation & Management”, which is continually ongoing since 2009 and has successfully enrolled over 300 students in the last over 3 years. The course is an online distance learning course, making it especially very effective for working professionals, … Continue reading IIPRD Offers 6 months Online Certificate Course
Read more »Roche v Cipla: Part 1: Validity of Patent
26th September, 2012 - 7:53 am
Categories:
IP Litigation
IP Practice in India
News & Updates
Pharma/Biotech Patent Litigations
0 Comments
In continuation of our previous post here, and following the availability of the 275 page judgement, we would discuss herein the various facets of the case and discuss one by one. This case actually involved two main issues as follows, Issue I. Whether Roche’s Indian Patent 196774 is invalid (liable to be revoked under S. … Continue reading Roche v Cipla: Part 1: Validity of Patent
Read more »Cipla won the landmark Roche v Cipla Litigation
8th September, 2012 - 10:46 am
Categories:
IP Practice in India
News & Updates
Pharma/Biotech Patent Litigations
0 Comments
Indian Generic manufacturer Cipla has won the landmark Roche v. Cipla Patent Infringement case in the Delhi High Court over Cipla’s Generic version of Anti-cancer Drug Erlotinib. The case is the first Patent Litigation in India post India’s 2005 Product Patent Regime which included public interest and pricing issues in addition to India’s Section 3d … Continue reading Cipla won the landmark Roche v Cipla Litigation
Read more »